ARCHIVE

• RESEARCH AND DEVELOPMENT NEWS IN BRIEF
  August 6, 2001

• Yoshitomi to Focus Only on Psychiatric Field
  August 6, 2001

• Dr Kawakita Urges Medical Facilities to Improve Quality of Services: Seminar
  August 6, 2001

• JST Select 10 Research Themes to Support in FY2001
  July 30, 2001

• 5 Products Including NovoRapid, Isuhuman, Flutide Recommended for Approval
  July 30, 2001

• Glivec Highly Effective against CML: Novartis Seminar
  July 30, 2001

• Stomach Cancer to Be Approved as New Indication for Taxol
  July 30, 2001

• Risperdal Effective for Positive Symptoms of Schizophrenia: Dr Grogg of Janssen
  July 30, 2001

• World Anti-cancer Market to Expand to \3 Trillion in 2005: Consultant
  July 30, 2001

• Int'l Study on Rofecoxib in OA Patients Begins: Banyu, Merck
  July 30, 2001

• Kyowa Hakko Enters PI in Europe for Anti-asthma KW-4490
  July 30, 2001

• Only 5% of Migraine Sufferers Seek Professional Help: GSK Seminar
  July 30, 2001

• Maker FTC Clarifies Rules Regarding Dispatch of Doctors Abroad
  July 30, 2001

• Zyvox Effectiveness against VRE Reported: Pharmacia Forum
  July 30, 2001

• Sanko Junyaku Patents Gene Amplification Method in the US
  July 30, 2001

• Edible Plants Effective for Peripheral Neuropathy: Takara Shuzo
  July 30, 2001

• REGULATORY NEWS IN BRIEF -2-
  July 30, 2001

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -2-
  July 30, 2001

• REGULATORY NEWS IN BRIEF -2-
  July 30, 2001

• Most Top Management of Wholesalers Regard Current Sales Prices as Abnormal: Survey
  July 30, 2001

ページ

• « 先頭
• ‹ Prev
• …
• 739
• 740
• 741
• 742
• 743
• 744
• 745
• 746
• 747
• …
• Next ›
• 最終 »